Navigation Links
Valeant Pharmaceuticals Receives Approval From FTC in Connection With Acquisition of Ortho Dermatologics and Dermik
Date:12/12/2011

MISSISSAUGA, Ontario, Dec. 12, 2011 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that the Federal Trade Commission (FTC) voted unanimously to approve the consent orders in connection with Valeant's acquisition of Dermik, a dermatology unit of Sanofi (EURONEXT: SAN and NYSE: SNY), and the U.S. assets of Ortho Dermatologics, a division of Janssen Pharmaceuticals, Inc.

As a result of the Commission vote, Valeant is now free to proceed with closing the transactions, subject to other closing conditions. Under the consent orders, Valeant is required to dissolve its collaboration related to Refissa and generic tretinoin emollient cream (TEC) and return those products to Spear Pharmaceuticals, who owns the Abbreviated New Drug Applications, as well as the divestiture of 1% clindamycin and 5% benzoyl peroxide gel (IDP-111), a generic version of Benzaclin, and 5% fluorouracil cream, (5-FU), an authorized generic of Efudex.

Valeant expects to complete the acquisition of the U.S. assets of Ortho Dermatologics today and Dermik by the end of 2011.

About Valeant Pharmaceuticals International, Inc.
Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics.  More information about Valeant Pharmaceuticals International, Inc. can be found at www.valeant.com.

Forward-Looking Statements
To the extent any statements made in this press release contain information that is not historical, these statements are forward-looking statements within
'/>"/>

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Valeant to Acquire Polish Products
2. GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
3. Valeant and Biovail Announce Results of Special Meetings of Shareholders
4. Valeant Pharmaceuticals Announces Redemption and Defeasance of 7.625% Senior Notes Due 2020 and 8.375% Senior Notes Due 2016
5. Valeant Pharmaceuticals Announces That Alexza Pharmaceuticals Has Received a Complete Response Letter for AZ-004 (Staccato® Loxapine) Inhalation Aerosol NDA
6. Valeant Pharmaceuticals Reports 2010 Third Quarter Financial Results
7. Valeant Declares Special Dividend and Plans to Create a Special Dividend Reinvestment Plan
8. Valeant Announces Pricing of Senior Notes
9. Valeant Pharmaceuticals Announces Appointment of Robert A. Ingram and Resignation of William M. Wells as Chairman
10. Valeant Pharmaceuticals Appoints Philip W. Loberg as Interim CFO
11. Regulatory Update - GSK and Valeant Receive Positive Opinion in Europe From the CHMP for Trobalt (Retigabine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... CLARA, Calif. , May 21, 2013 ... game-changing embedded-ultrasound platform, today announced the introduction ... that allows complete network-based communications with all ... its latest embedded-ultrasound technology, including this new ... Sao Paulo, Brazil from ...
(Date:5/21/2013)...  Vasomedical, Inc. (OTC BB: VASO) (the "Company"), a diversified ... of medical devices and in the domestic sale of diagnostic ... , President and CEO of Vasomedical, Inc. will present ... May 30, 2013 in New York City ... Company,s presentation is scheduled to begin at 9:30 a.m. EDT. ...
(Date:5/21/2013)... Calif. , May 21, 2013   ... announced today the publication of study results involving ... CyberKnife® Robotic Radiosurgery System, the most widely used ... The study followed 304 patients for a median ... post-treatment and found that 97 percent of patients ...
Breaking Medicine Technology:Cephasonics Unveils Next-Generation Wireless-Imaging Technology for cQuest Ultrasound Hardware Platforms 2Vasomedical, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 2New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 3
... THE WOODLANDS, Texas, Dec. 6, 2011 The US Oncology ... M.D., New York Oncology Hematology , and J. Russell ... discussion with oncologists on value-based reimbursement and its impact on the ... Dec. 13 at 1:00 p.m. ET/ 12 p.m. CT/ 11 a.m. ...
... and AMSTERDAM, Dec. 6, 2011 Agendia, an ... of formalin fixed, paraffin embedded tissue technology applied ... Delivering Agendia,s tests in a paraffin embedded tissue ... the superior science, development and validation found in ...
Cached Medicine Technology:The US Oncology Network to Present Webinar on Value-Based Reimbursement 2Agendia Introduces the SYMPHONY™ Breast Cancer Profile With Paraffin Embedded Tissue 2
(Date:5/21/2013)... Antonio, TX (PRWEB) May 21, 2013 ... from the Texas Department of Aging and Disability Services. ... visits and employee interviews, ContinuCare Home Health was ... , The review is part of the Department of ... array of aging and disability services, supports and ...
(Date:5/21/2013)... CA (PRWEB) May 21, 2013 ... Annual EB-5 Investment Summit: Dealmakers Conference in Long ... Conference will focus on exploring alternative finance through ... the latest market, legal and economic information, and ... and legal professionals within the EB-5 industry. ...
(Date:5/21/2013)... According to a May 13, 2013 New ... Botox,” Botox injections have become the most popular ... (Go to goo.gl/8iYbD). Although it is mostly associated with women, ... injection makes facial wrinkles less visible by paralyzing facial muscles. ... three months. This means that people who are conscious about ...
(Date:5/21/2013)... Diversity Focus, a non-profit organization striving to ... in the Creative Corridor region, is releasing results for ... conference on Thursday, May 23rd at 10:30 a.m. ... , The survey is a critical component ... that attract, nurture and retain people of diverse backgrounds, ...
(Date:5/21/2013)... A paper recently published in the New England ... scientists at the University of Colorado School of Medicine ... fibrosis can be used to identify individuals at risk ... a fairly common variant of the gene for mucin-5B, ... produced by the bronchial tubes. While this variant of ...
Breaking Medicine News(10 mins):Health News:ContinuCare Home Health, Inc. Receives Perfect Report from the Texas Department of Aging and Disability Services 2Health News:Artisan Business Group to Host EB-5 Investment Conference in Long Beach, California 2Health News:Botox – Is the World’s Most Popular Cosmetic Procedure Safe? 2Health News:Diversity Focus Announces Results from 2013 Creative Corridor Survey at News Conference on Thursday, May 23rd at 10:30 a.m. 2Health News:Researchers find genetic risk factor for pulmonary fibrosis 2
... experts say , TUESDAY, Dec. 29 (HealthDay News) -- Winter,s ... but they pose extra hazards for elderly people, experts say. ... adults over age 65 in the United States. Some 1.8 ... departments for falls in 2005, and 15,800 died from their ...
... , ... System and Robert Gerson, MD, Board Certified Plastic Surgeon, will be offering free cosmetic ... ... Health System and Robert Gerson, MD, Board Certified Plastic Surgeon, will be offering free ...
... YORK, Dec. 29 Nutritionist Judy Pentra, of Patients Medical , ... can be a vulnerable time for people trying to lose weight and ... holidays and many resolve to lose the weight in January, however, 70 ... of the biggest problems for busy executives trying to get in shape ...
... N.Y. -- The role of pharmacists hasn,t received much ... care. But national and regional studies show that when ... treatment costs and improve outcomes. A study on diabetic ... and Pharmaceutical Sciences identified cost savings with improvements in ...
... , Michigan Business and Professional Association ... Dec. 29 Eighty-three percent of the owners of small ... care plan as a public option for insurance, according to ... Business and Professional Association (MBPA) and the Michigan ...
... , , SAN JOSE, Calif. , ... 2009 a year of success in advocacy, research support and ... PF is a fatal disease that has no known cause, ... grassroots fundraising efforts in 2009, further advancing the effort to ...
Cached Medicine News:Health News:Caution Can Help Keep Elderly Safe During Winter 2Health News:Patients Medical Warns Against The Manhattan Diet 2Health News:Pharmacists improve care of diabetics while cutting costs, UB research shows 2Health News:Pharmacists improve care of diabetics while cutting costs, UB research shows 3Health News:83 Percent of Small Businesses Say 'No' to Health Care Public Option, 89 Percent Say Government Cannot Provide Adequate Health Care 2Health News:83 Percent of Small Businesses Say 'No' to Health Care Public Option, 89 Percent Say Government Cannot Provide Adequate Health Care 3Health News:Coalition for Pulmonary Fibrosis Celebrates Successes Despite Year of Economic Downturn 2Health News:Coalition for Pulmonary Fibrosis Celebrates Successes Despite Year of Economic Downturn 3Health News:Coalition for Pulmonary Fibrosis Celebrates Successes Despite Year of Economic Downturn 4
... Millar Mikro-Tip pressure intravascular catheters ... accurate method of measuring pressures in ... reusable, thromboresistant Mikro-Tip catheters are ideal ... catheters range in size from 2 ...
... Sensor Intravascular Mikro-Tip Pressure Catheters; Millar ... dual pressure sensor catheters for simultaneous ... are suitable for measuring pressure gradients ... across a vascular stenosis. The catheters ...
... Mikro-Tip pressure intravascular catheters provide a ... of measuring pressures in the heart ... Mikro-Tip catheters are ideal for high ... in size from 2 to 7 ...
... Millar Mikro-Tip pressure intravascular catheters ... accurate method of measuring pressures in ... reusable, thromboresistant Mikro-Tip catheters are ideal ... catheters range in size from 2 ...
Medicine Products: